Regulation of c-Src Nonreceptor Tyrosine Kinase Activity by Bengamide A through Inhibition of Methionine Aminopeptidases

Chemistry and Biology

Volumn 14, Issue 7, 2007, Pages 764-774

  Hu, Xiaoyi ^a   Dang, Yongjun ^a   Tenney, Karen ^b   Crews, Phillip ^b   Tsai, Chiawei W ^a   Sixt, Katherine M ^a   Cole, Philip A ^a   Liu, Jun O ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

CHEMBIO

Indexed keywords

AMINOPEPTIDASE; AZEPINE DERIVATIVE; METHIONYL AMINOPEPTIDASE; PROTEIN KINASE P60; PROTEIN TYROSINE KINASE; PROTEINASE INHIBITOR;

ANIMAL; ARTICLE; CELL FRACTIONATION; CELL LINE; DRUG ANTAGONISM; ENZYMOLOGY; HUMAN; METABOLISM;

AMINOPEPTIDASES; ANIMALS; AZEPINES; CELL LINE; HUMANS; PROTEASE INHIBITORS; PROTO-ONCOGENE PROTEINS PP60(C-SRC); SRC-FAMILY KINASES; SUBCELLULAR FRACTIONS;

EID: 34447547502     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chembiol.2007.05.010     Document Type: Article

References (49)

1. Lowther W.T., and Matthews B.W. Structure and function of the methionine aminopeptidases. Biochim. Biophys. Acta 1477 (2000) 157-167
2. Chang S.Y., McGary E.C., and Chang S. Methionine aminopeptidase gene of Escherichia coli is essential for cell growth. J. Bacteriol. 171 (1989) 4071-4072
3. Li X., and Chang Y.H. Amino-terminal protein processing in Saccharomyces cerevisiae is an essential function that requires two distinct methionine aminopeptidases. Proc. Natl. Acad. Sci. USA 92 (1995) 12357-12361
4. Griffith E.C., Su Z., Turk B.E., Chen S., Chang Y.H., Wu Z., Biemann K., and Liu J.O. Methionine aminopeptidase (type 2) is the common target for angiogenesis inhibitors AGM-1470 and ovalicin. Chem. Biol. 4 (1997) 461-471
5. Sin N., Meng L., Wang M.Q., Wen J.J., Bornmann W.G., and Crews C.M. The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2. Proc. Natl. Acad. Sci. USA 94 (1997) 6099-6103
6. Zhang Y., Griffith E.C., Sage J., Jacks T., and Liu J.O. Cell cycle inhibition by the anti-angiogenic agent TNP-470 is mediated by p53 and p21WAF1/CIP1. Proc. Natl. Acad. Sci. USA 97 (2000) 6427-6432
7. Yeh J.R., Mohan R., and Crews C.M. The antiangiogenic agent TNP-470 requires p53 and p21CIP/WAF for endothelial cell growth arrest. Proc. Natl. Acad. Sci. USA 97 (2000) 12782-12787
8. Mukherji M., Bell R., Supekova L., Wang Y., Orth A.P., Batalov S., Miraglia L., Huesken D., Lange J., Martin C., et al. Genome-wide functional analysis of human cell-cycle regulators. Proc. Natl. Acad. Sci. USA 103 (2006) 14819-14824
9. Wang J., Sheppard G.S., Lou P., Kawai M., BaMaung N., Erickson S.A., Tucker-Garcia L., Park C., Bouska J., Wang Y.C., et al. Tumor suppression by a rationally designed reversible inhibitor of methionine aminopeptidase-2. Cancer Res. 63 (2003) 7861-7869
10. Satchi-Fainaro R., Mamluk R., Wang L., Short S.M., Nagy J.A., Feng D., Dvorak A.M., Dvorak H.F., Puder M., Mukhopadhyay D., et al. Inhibition of vessel permeability by TNP-470 and its polymer conjugate, caplostatin. Cancer Cell 7 (2005) 251-261
11. Lu J., Chong C.R., Hu X., and Liu J.O. Fumarranol, a rearranged fumagillin analogue that inhibits angiogenesis in vivo. J. Med. Chem. 49 (2006) 5645-5648
12. Hu X., Addlagatta A., Matthews B.W., and Liu J.O. Identification of pyridinylpyrimidines as inhibitors of human methionine aminopeptidases. Angew. Chem. Int. Ed. Engl. 45 (2006) 3772-3775
13. Hu X., Addlagatta A., Lu J., Matthews B.W., and Liu J.O. Elucidation of the function of type 1 human methionine aminopeptidase during cell cycle progression. Proc. Natl. Acad. Sci. USA 103 (2006) 18148-18153
14. Quinoa E., Adamczeski M., Crews P., and Bakus G.J. Bengamides, heterocyclic anthelmintics from a Jaspidae marine sponge. J. Org. Chem. 51 (1986) 4494-4497
15. Adamczeski M., Quinoa E., and Crews P. Novel sponge-derived amino acids. 11. The entire absolute stereochemistry of the bengamides. J. Org. Chem. 55 (1990) 240-242
16. Kinder F.R., Versace R.W., Bair K.W., Bontempo J.M., Cesarz D., Chen S., Crews P., Czuchta A.M., Jagoe C.T., Mou Y., et al. Synthesis and antitumor activity of ester-modified analogues of bengamide B. J. Med. Chem. 44 (2001) 3692-3699
17. Thale Z., Kinder F.R., Bair K.W., Bontempo J., Czuchta A.M., Versace R.W., Phillips P.E., Sanders M.L., Wattanasin S., and Crews P. Bengamides revisited: new structures and antitumor studies. J. Org. Chem. 66 (2001) 1733-1741
18. Dumez H., Gall H., Capdeville R., Dutreix C., van Oosterom A.T., and Giaccone G. A phase I and pharmacokinetic study of LAF389 administered to patients with advanced cancer. Anticancer Drugs 18 (2007) 219-225
19. Towbin H., Bair K.W., DeCaprio J.A., Eck M.J., Kim S., Kinder F.R., Morollo A., Mueller D.R., Schindler P., Song H.K., et al. Proteomics-based target identification: bengamides as a new class of methionine aminopeptidase inhibitors. J. Biol. Chem. 278 (2003) 52964-52971
20. Kim S., LaMontagne K., Sabio M., Sharma S., Versace R.W., Yusuff N., and Phillips P.E. Depletion of methionine aminopeptidase 2 does not alter cell response to fumagillin or bengamides. Cancer Res. 64 (2004) 2984-2987
21. Bernier S.G., Taghizadeh N., Thompson C.D., Westlin W.F., and Hannig G. Methionine aminopeptidases type I and type II are essential to control cell proliferation. J. Cell. Biochem. 95 (2005) 1191-1203
22. Yeh J.R., Ju R., Brdlik C.M., Zhang W., Zhang Y., Matyskiela M.E., Shotwell J.D., and Crews C.M. Targeted gene disruption of methionine aminopeptidase 2 results in an embryonic gastrulation defect and endothelial cell growth arrest. Proc. Natl. Acad. Sci. USA 103 (2006) 10379-10384
23. Varshavsky A. The N-end rule: functions, mysteries, uses. Proc. Natl. Acad. Sci. USA 93 (1996) 12142-12149
24. Perrier J., Durand A., Giardina T., and Puigserver A. Catabolism of intracellular N-terminal acetylated proteins: involvement of acylpeptide hydrolase and acylase. Biochimie 87 (2005) 673-685
25. Boutin J.A. Myristoylation. Cell. Signal. 9 (1997) 15-35
26. Massiere F., and Badet-Denisot M.A. The mechanism of glutamine-dependent amidotransferases. Cell. Mol. Life Sci. 54 (1998) 205-222
27. Turk B.E., Griffith E.C., Wolf S., Biemann K., Chang Y.H., and Liu J.O. Selective inhibition of amino-terminal methionine processing by TNP-470 and ovalicin in endothelial cells. Chem. Biol. 6 (1999) 823-833
28. Chen S., Vetro J.A., and Chang Y.H. The specificity in vivo of two distinct methionine aminopeptidases in Saccharomyces cerevisiae. Arch. Biochem. Biophys. 398 (2002) 87-93
29. Miller D.M., Kurzban G.P., Mendoza J.A., Chirgwin J.M., Hardies S.C., and Horowitz P.M. Recombinant bovine rhodanese: purification and comparison with bovine liver rhodanese. Biochim. Biophys. Acta 1121 (1992) 286-292
30. Raftery M.J., Harrison C.A., Alewood P., Jones A., and Geczy C.L. Isolation of the murine S100 protein MRP14 (14 kDa migration-inhibitory-factor-related protein) from activated spleen cells: characterization of post-translational modifications and zinc binding. Biochem. J. 316 (1996) 285-293
31. Schmitz S., Clayton J., Nongthomba U., Prinz H., Veigel C., Geeves M., and Sparrow J. Drosophila ACT88F indirect flight muscle-specific actin is not N-terminally acetylated: a mutation in N-terminal processing affects actin function. J. Mol. Biol. 295 (2000) 1201-1210
32. Bjorge J.D., Jakymiw A., and Fujita D.J. Selected glimpses into the activation and function of Src kinase. Oncogene 19 (2000) 5620-5635
33. Chackalaparampil I., and Shalloway D. Altered phosphorylation and activation of pp60c-src during fibroblast mitosis. Cell 52 (1988) 801-810
34. Roche S., Fumagalli S., and Courtneidge S.A. Requirement for Src family protein tyrosine kinases in G2 for fibroblast cell division. Science 269 (1995) 1567-1569
35. Vaughan M.D., Sampson P.B., and Honek J.F. Methionine in and out of proteins: targets for drug design. Curr. Med. Chem. 9 (2002) 385-409
36. Erpel T., and Courtneidge S.A. Src family protein tyrosine kinases and cellular signal transduction pathways. Curr. Opin. Cell Biol. 7 (1995) 176-182
37. Cole P.A., Shen K., Qiao Y., and Wang D. Protein tyrosine kinases Src and Csk: a tail's tale. Curr. Opin. Chem. Biol. 7 (2003) 580-585
38. Northcote P.T., John W., and Murray H.G. Pateamine: a potent cytotoxin from the New Zealand Marine sponge, mycale sp. Tetrahedron Lett. 32 (1991) 6411-6414
39. Low W.K., Dang Y., Schneider-Poetsch T., Shi Z., Choi N.S., Merrick W.C., Romo D., and Liu J.O. Inhibition of eukaryotic translation initiation by the marine natural product pateamine A. Mol. Cell 20 (2005) 709-722
40. Liu J., Farmer Jr. J.D., Lane W.S., Friedman J., Weissman I., and Schreiber S.L. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 66 (1991) 807-815
41. Qiao Y., Molina H., Pandey A., Zhang J., and Cole P.A. Chemical rescue of a mutant enzyme in living cells. Science 311 (2006) 1293-1297
42. Yoshida T., Kaneko Y., Tsukamoto A., Han K., Ichinose M., and Kimura S. Suppression of hepatoma growth and angiogenesis by a fumagillin derivative TNP470: possible involvement of nitric oxide synthase. Cancer Res. 58 (1998) 3751-3756
43. Mauriz J.L., Linares P., Macias R.I., Jorquera F., Honrado E., Olcoz J.L., Gonzalez P., and Gonzalez-Gallego J. TNP-470 inhibits oxidative stress, nitric oxide production and nuclear factor kappa B activation in a rat model of hepatocellular carcinoma. Free Radic. Res. 37 (2003) 841-848
44. Luo Q.L., Li J.Y., Jiu Z.Y., Chen L.L., Li J., Qian Z., Shen Q., Li Y., Lushington G.H., Ye Q.Z., et al. Discovery and structural modification of inhibitors of methionine aminopeptidases from Escherichia coli and Saccharomyces cerevisiae. J. Med. Chem. 46 (2003) 2631-2640
45. Zhang Y., Yeh J.R., Mara A., Ju R., Hines J.F., Cirone P., Griesbach H.L., Schneider I., Slusarski D.C., Holley S.A., et al. A chemical and genetic approach to the mode of action of fumagillin. Chem. Biol. 13 (2006) 1001-1009
46. Jopling C., and den Hertog J. Fyn/Yes and non-canonical Wnt signalling converge on RhoA in vertebrate gastrulation cell movements. EMBO Rep. 6 (2005) 426-431
47. Addlagatta A., Hu X., Liu J.O., and Matthews B.W. Structural basis for the functional differences between type I and type II human methionine aminopeptidases. Biochemistry 44 (2005) 14741-14749
48. Gaschet J., and Hsu V.W. Distribution of ARF6 between membrane and cytosol is regulated by its GTPase cycle. J. Biol. Chem. 274 (1999) 20040-20045
49. Dang Y., Kedersha N., Low W.K., Romo D., Gorospe M., Kaufman R., Anderson P., and Liu J.O. Eukaryotic initiation factor 2alpha-independent pathway of stress granule induction by the natural product pateamine A. J. Biol. Chem. 281 (2006) 32870-32878